These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28432583)

  • 1. Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review.
    Mochcovitch MD; da Rocha Freire RC; Garcia RF; Nardi AE
    Clin Drug Investig; 2017 Aug; 37(8):737-743. PubMed ID: 28432583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine in the treatment of generalized anxiety disorder.
    Kornstein SG; Russell JM; Spann ME; Crits-Christoph P; Ball SG
    Expert Rev Neurother; 2009 Feb; 9(2):155-65. PubMed ID: 19210191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety symptom severity and functional recovery or relapse.
    Stein DJ; Bandelow B; Dolberg OT; Andersen HF; Baldwin DS
    Ann Clin Psychiatry; 2009; 21(2):81-8. PubMed ID: 19439157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder.
    Baldwin DS; Loft H; Florea I
    Int Clin Psychopharmacol; 2012 Jul; 27(4):197-207. PubMed ID: 22475889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term clinical course of generalized anxiety disorder.
    Keller MB
    J Clin Psychiatry; 2002; 63 Suppl 8():11-6. PubMed ID: 12044103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.
    Pollack MH
    J Clin Psychiatry; 2001; 62 Suppl 19():20-5. PubMed ID: 11577787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder.
    Bodkin JA; Allgulander C; Llorca PM; Spann ME; Walker DJ; Russell JM; Ball SG
    Hum Psychopharmacol; 2011 Apr; 26(3):258-66. PubMed ID: 21678494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based pharmacotherapy of Generalized Anxiety Disorder.
    Baldwin DS; Polkinghorn C
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):293-302. PubMed ID: 15576000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized anxiety disorder: how to treat, and for how long?
    Lam RW
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():10-5. PubMed ID: 24931538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological functioning in young subjects with generalized anxiety disorder with and without pharmacotherapy.
    Tempesta D; Mazza M; Serroni N; Moschetta FS; Di Giannantonio M; Ferrara M; De Berardis D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():236-41. PubMed ID: 23796524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
    Ooi SL; Henderson P; Pak SC
    J Altern Complement Med; 2018 Aug; 24(8):770-780. PubMed ID: 29641222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.
    Yonkers KA; Bruce SE; Dyck IR; Keller MB
    Depress Anxiety; 2003; 17(3):173-9. PubMed ID: 12768651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review.
    Perna G; Alciati A; Riva A; Micieli W; Caldirola D
    Curr Psychiatry Rep; 2016 Mar; 18(3):23. PubMed ID: 26830881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of anxiety disorders: a review of double-blind studies.
    Thuile J; Even C; Rouillon F
    Curr Opin Psychiatry; 2009 Jan; 22(1):84-9. PubMed ID: 19122539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
    Beesdo K; Hartford J; Russell J; Spann M; Ball S; Wittchen HU
    J Anxiety Disord; 2009 Dec; 23(8):1064-71. PubMed ID: 19643572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A literature review of quetiapine for generalized anxiety disorder.
    Kreys TJ; Phan SV
    Pharmacotherapy; 2015 Feb; 35(2):175-88. PubMed ID: 25689246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.